My name is Srini Bhylahalli. founder & CEO of Trisail Medical, a Singapore based startup developing a minimally invasive medical device in the area of Cardiology. I have 20+ years' experience in the healthcare industry in senior leadership roles.
Trisail Medical, a spin-off from the National Heart Centre Singapore, is developing the world's simplest and fastest transcatheter medical device to treat tricuspid regurgitation, a heart valve disease affecting >60 million people globally. The company has strong pre-clinical safety data and is raising Series A financing to complete First-in-Human studies. We welcome potential investors and collaborators who wish to learn more about our technology and company to reach out and discuss the opportunity.
Healthcare industry professional with strong business and scientific expertise. Experience in new venture creation, fundraising, strategic alliances, business development & leadership responsibilities in developing new businesses. Broad working experience and professional network, across Asia, Europe and North America, with key executives in small and large healthcare companies, investors, clinical key opinion leaders, top-notch academic scientists, incubators and government organizations. In addition to my current role as founder & CEO of Trisail Medical, I'm the founder & chairman of Intellimed Healthcare, a Singapore headquartered company commercializing medical technologies (AI/digital health + medical devices) with a focus on the ASEAN markets in the areas of chronic wound management and cardiology. Domain knowledge: Lifesciences, Pharma/Biotech, Medical devices, Healthcare Technical experience: Product development, Intellectual property portfolio strategy, Licensing, Valuation, Technology commercialization road maps, writing business plans, investment analysis, Start-up mentoring.
Trisail Medical is developing a novel transcatheter tricuspid valve repair device. We welcome partners with interest in cardiac implant/heart valve area. Opportunity for joint product development, testing,clinical development, grants funding & licensing.